{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T18:33:39Z","timestamp":1783103619303,"version":"3.54.6"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Pathology"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.humpath.2026.106072","type":"journal-article","created":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T16:26:19Z","timestamp":1770395179000},"page":"106072","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["S100 expression and SDHB status define distinct biological subsets of bladder paraganglioma"],"prefix":"10.1016","volume":"171","author":[{"given":"Huili","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0990-1115","authenticated-orcid":false,"given":"Andres","family":"Matoso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.humpath.2026.106072_bib1","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1002\/(SICI)1097-0142(20000215)88:4<844::AID-CNCR15>3.0.CO;2-I","article-title":"Paraganglioma of the urinary bladder: can biologic potential be predicted?","volume":"88","author":"Cheng","year":"2000","journal-title":"Cancer"},{"key":"10.1016\/j.humpath.2026.106072_bib2","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1016\/j.urology.2014.01.007","article-title":"The genetic basis of pheochromocytoma and paraganglioma: implications for management","volume":"83","author":"Shuch","year":"2014","journal-title":"Urology"},{"key":"10.1016\/j.humpath.2026.106072_bib3","first-page":"484","article-title":"S100 protein-positive sustentacular cells in malignant and locally aggressive adrenal pheochromocytomas","volume":"115","author":"Unger","year":"1991","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.humpath.2026.106072_bib4","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1111\/j.1365-2559.1986.tb02539.x","article-title":"Demonstration of S-100 protein in sustentacular cells of phaeochromocytomas and paragangliomas","volume":"10","author":"Schroder","year":"1986","journal-title":"Histopathology"},{"key":"10.1016\/j.humpath.2026.106072_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.beem.2024.101958","article-title":"Recent progress in the pathologic classification of pheochromocytomas and paragangliomas","volume":"38","author":"Mete","year":"2024","journal-title":"Best Pract Res Clin Endocrinol Metabol"},{"key":"10.1016\/j.humpath.2026.106072_bib6","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1471-2490-13-22","article-title":"Pheochromocytoma of the urinary bladder: a systematic review of the contemporary literature","volume":"13","author":"Beilan","year":"2013","journal-title":"BMC Urol"},{"key":"10.1016\/j.humpath.2026.106072_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.urolonc.2017.02.006","article-title":"Genitourinary paraganglioma: demographic, pathologic, and clinical characteristics in the surveillance, epidemiology, and end results database (2000-2012)","volume":"35","author":"Purnell","year":"2017","journal-title":"Urol Oncol"},{"key":"10.1016\/j.humpath.2026.106072_bib8","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1056\/NEJM195307022490106","article-title":"Pheochromocytoma of the urinary bladder","volume":"249","author":"Zimmerman","year":"1953","journal-title":"N Engl J Med"},{"key":"10.1016\/j.humpath.2026.106072_bib9","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1111\/cen.15058","article-title":"Diagnosis and management of urinary bladder paragangliomas: a Sino-American-European retrospective observational study","volume":"101","author":"Pang","year":"2024","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.humpath.2026.106072_bib10","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s00345-021-03851-x","article-title":"Differences in clinical presentation and management between pre- and postsurgical diagnoses of urinary bladder paraganglioma: is there clinical relevance? A systematic review","volume":"40","author":"Li","year":"2022","journal-title":"World J Urol"},{"key":"10.1016\/j.humpath.2026.106072_bib11","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1023\/A:1015253427161","article-title":"Malignant paraganglioma of the urinary bladder. A case report","volume":"33","author":"Ansari","year":"2001","journal-title":"Int Urol Nephrol"},{"key":"10.1016\/j.humpath.2026.106072_bib12","doi-asserted-by":"crossref","first-page":"e25","DOI":"10.1016\/j.urology.2014.11.006","article-title":"Patients with urinary bladder paragangliomas: a compiled case series from a literature review for clinical management","volume":"85","author":"Henderson","year":"2015","journal-title":"Urology"},{"key":"10.1016\/j.humpath.2026.106072_bib13","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1007\/s00261-022-03443-2","article-title":"Bladder paragangliomas: a pictorial review","volume":"47","author":"Withey","year":"2022","journal-title":"Abdom Radiol"},{"key":"10.1016\/j.humpath.2026.106072_bib14","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.ejim.2018.01.015","article-title":"Incidence of pheochromocytoma and sympathetic paraganglioma in the Netherlands: a nationwide study and systematic review","volume":"51","author":"Berends","year":"2018","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.humpath.2026.106072_bib15","doi-asserted-by":"crossref","first-page":"105","DOI":"10.21037\/gs.2019.10.25","article-title":"Pheochromocytoma\/paraganglioma: recent updates in genetics, biochemistry, immunohistochemistry, metabolomics, imaging and therapeutic options","volume":"9","author":"Antonio","year":"2020","journal-title":"Gland Surg"},{"key":"10.1016\/j.humpath.2026.106072_bib16","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1007\/s12022-021-09675-0","article-title":"Challenges in paragangliomas and pheochromocytomas: from histology to molecular immunohistochemistry","volume":"32","author":"Juhlin","year":"2021","journal-title":"Endocr Pathol"},{"key":"10.1016\/j.humpath.2026.106072_bib17","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1007\/s40618-024-02509-w","article-title":"Genetics of urinary bladder paragangliomas: a multi-center study of a Chinese cohort","volume":"48","author":"Jiang","year":"2025","journal-title":"J Endocrinol Investig"},{"key":"10.1016\/j.humpath.2026.106072_bib18","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1007\/s12022-022-09704-6","article-title":"Overview of the 2022 WHO classification of paragangliomas and pheochromocytomas","volume":"33","author":"Mete","year":"2022","journal-title":"Endocr Pathol"},{"key":"10.1016\/j.humpath.2026.106072_bib19","doi-asserted-by":"crossref","first-page":"6053","DOI":"10.1016\/j.asjsur.2023.09.044","article-title":"Genetic testing and innovative surgery for familial urinary bladder paraganglioma: report of two cases and literature review","volume":"46","author":"Mai","year":"2023","journal-title":"Asian J Surg"},{"key":"10.1016\/j.humpath.2026.106072_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.12968\/hmed.2021.0656","article-title":"Urinary bladder paraganglioma with a family history of neurofibromatosis type 1 treated with partial cystectomy","volume":"83","author":"Hald","year":"2022","journal-title":"Br J Hosp Med"},{"key":"10.1016\/j.humpath.2026.106072_bib21","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ccell.2017.01.001","article-title":"Comprehensive molecular characterization of pheochromocytoma and paraganglioma","volume":"31","author":"Fishbein","year":"2017","journal-title":"Cancer Cell"},{"key":"10.1016\/j.humpath.2026.106072_bib22","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1210\/endrev\/bnab019","article-title":"Personalized management of pheochromocytoma and paraganglioma","volume":"43","author":"N\u00f6lting","year":"2022","journal-title":"Endocr Rev"},{"key":"10.1016\/j.humpath.2026.106072_bib23","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s12022-016-9439-2","article-title":"Urinary bladder paragangliomas: analysis of succinate dehydrogenase and outcome","volume":"27","author":"Gupta","year":"2016","journal-title":"Endocr Pathol"},{"key":"10.1016\/j.humpath.2026.106072_bib24","doi-asserted-by":"crossref","first-page":"e131","DOI":"10.1016\/j.clgc.2016.06.006","article-title":"Succinate dehydrogenase B (SDHB)-associated bladder paragangliomas","volume":"15","author":"Srirangalingam","year":"2017","journal-title":"Clin Genitourin Cancer"},{"key":"10.1016\/j.humpath.2026.106072_bib25","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1159\/000030367","article-title":"Paraganglioma of the urinary bladder: a case report and review of the Japanese literature","volume":"62","author":"Shono","year":"1999","journal-title":"Urol Int"},{"key":"10.1016\/j.humpath.2026.106072_bib26","doi-asserted-by":"crossref","first-page":"2811","DOI":"10.1210\/clinem\/dgac427","article-title":"Presentation, management, and outcomes of urinary bladder paraganglioma: results from a multicenter study","volume":"107","author":"Yu","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.humpath.2026.106072_bib27","doi-asserted-by":"crossref","first-page":"402","DOI":"10.4103\/0974-7796.152058","article-title":"Paraganglioma of urinary bladder","volume":"7","author":"Priyadarshi","year":"2015","journal-title":"Urol Ann"},{"key":"10.1016\/j.humpath.2026.106072_bib28","doi-asserted-by":"crossref","first-page":"e765","DOI":"10.1016\/j.clgc.2017.03.010","article-title":"Paraganglioma of the urinary bladder: a series of 22 cases in a single center","volume":"15","author":"Zhai","year":"2017","journal-title":"Clin Genitourin Cancer"},{"issue":"Pt 3","key":"10.1016\/j.humpath.2026.106072_bib29","first-page":"431","article-title":"An immunohistochemical study of human postnatal paraganglia associated with the urinary bladder","volume":"181","author":"Dixon","year":"1992","journal-title":"J Anat"},{"key":"10.1016\/j.humpath.2026.106072_bib30","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1136\/jcp.43.1.13","article-title":"Paraganglial cells of urinary bladder and prostate: potential diagnostic problem","volume":"43","author":"Rode","year":"1990","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.humpath.2026.106072_bib31","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1038\/modpathol.2013.76","article-title":"GATA3 expression in paragangliomas: a pitfall potentially leading to misdiagnosis of urothelial carcinoma","volume":"26","author":"So","year":"2013","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2026.106072_bib32","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.humpath.2020.07.010","article-title":"Immunohistochemical distinction of paragangliomas from epithelial neuroendocrine tumors-gangliocytic duodenal and cauda equina paragangliomas align with epithelial neuroendocrine tumors","volume":"103","author":"Mamilla","year":"2020","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2026.106072_bib33","doi-asserted-by":"crossref","first-page":"T123","DOI":"10.1530\/ERC-15-0261","article-title":"15 years of paraganglioma: pathology of pheochromocytoma and paraganglioma","volume":"22","author":"Tischler","year":"2015","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.humpath.2026.106072_bib34","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1002\/path.1535","article-title":"Multiparameter DNA flow-sorting demonstrates diploidy and SDHD wild-type gene retention in the sustentacular cell compartment of head and neck paragangliomas: chief cells are the only neoplastic component","volume":"202","author":"Douwes Dekker","year":"2004","journal-title":"J Pathol"},{"key":"10.1016\/j.humpath.2026.106072_bib35","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s12022-020-09633-2","article-title":"Immunohistochemical staining for SOX10 and SDHB in SDH-deficient paragangliomas indicates that sustentacular cells are not neoplastic","volume":"31","author":"Powers","year":"2020","journal-title":"Endocr Pathol"},{"key":"10.1016\/j.humpath.2026.106072_bib36","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1038\/s41698-025-01145-8","article-title":"Postnatal sustentacular cells as chromaffin progenitors and tumor cells of origin in VHL-related paragangliomas","volume":"9","author":"Bullova","year":"2025","journal-title":"npj Precis Oncol"},{"key":"10.1016\/j.humpath.2026.106072_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.cdev.2021.203686","article-title":"Schwann cell precursors: where they come from and where they go","volume":"166","author":"Solovieva","year":"2021","journal-title":"Cells Dev"},{"key":"10.1016\/j.humpath.2026.106072_bib38","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/j.1365-2559.1991.tb00877.x","article-title":"Immunocytochemistry of paragangliomas--value of staining for S-100 protein and glial fibrillary acid protein in diagnosis and prognosis","volume":"18","author":"Achilles","year":"1991","journal-title":"Histopathology"},{"key":"10.1016\/j.humpath.2026.106072_bib39","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0115400","article-title":"SOX10 transactivates S100B to suppress Schwann cell proliferation and to promote myelination","volume":"9","author":"Fujiwara","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.humpath.2026.106072_bib40","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1083\/jcb.200912142","article-title":"Sox10 is required for Schwann cell identity and progression beyond the immature Schwann cell stage","volume":"189","author":"Finzsch","year":"2010","journal-title":"J Cell Biol"},{"key":"10.1016\/j.humpath.2026.106072_bib41","article-title":"Specific marker expression and cell state of Schwann cells during culture in vitro","volume":"10","author":"Liu","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.humpath.2026.106072_bib42","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1111\/j.1365-2559.2009.03415.x","article-title":"Diagnostic value of Sox10 immunohistochemical staining for the detection of metastatic melanoma in sentinel lymph nodes","volume":"55","author":"Blochin","year":"2009","journal-title":"Histopathology"},{"key":"10.1016\/j.humpath.2026.106072_bib43","doi-asserted-by":"crossref","first-page":"e1937","DOI":"10.1210\/clinem\/dgaa982","article-title":"Metastatic pheochromocytomas and abdominal paragangliomas","volume":"106","author":"Granberg","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.humpath.2026.106072_bib44","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s12022-024-09830-3","article-title":"The molecular classification of pheochromocytomas and paragangliomas: discovering the genomic and immune landscape of metastatic disease","volume":"35","author":"de Bresser","year":"2024","journal-title":"Endocr Pathol"},{"key":"10.1016\/j.humpath.2026.106072_bib45","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.107108","article-title":"Transcriptional subtypes on immune microenvironment and predicting postoperative recurrence and metastasis in human pheochromocytoma and paraganglioma","volume":"14","author":"Liu","year":"2025","journal-title":"eLife"},{"key":"10.1016\/j.humpath.2026.106072_bib46","doi-asserted-by":"crossref","first-page":"3822","DOI":"10.1210\/jc.2007-0709","article-title":"Succinate dehydrogenase B gene mutations predict survival in patients with malignant pheochromocytomas or paragangliomas","volume":"92","author":"Amar","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.humpath.2026.106072_bib47","doi-asserted-by":"crossref","first-page":"T91","DOI":"10.1530\/ERC-15-0268","article-title":"15 years of paraganglioma: clinical manifestations of paraganglioma syndromes types 1-5","volume":"22","author":"Benn","year":"2015","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.humpath.2026.106072_bib48","doi-asserted-by":"crossref","first-page":"4505","DOI":"10.1210\/jc.2006-0423","article-title":"High frequency of SDHB germline mutations in patients with malignant catecholamine-producing paragangliomas: implications for genetic testing","volume":"91","author":"Brouwers","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.humpath.2026.106072_bib49","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1016\/j.ejca.2011.07.016","article-title":"Plasma methoxytyramine: a novel biomarker of metastatic pheochromocytoma and paraganglioma in relation to established risk factors of tumour size, location and SDHB mutation status","volume":"48","author":"Eisenhofer","year":"2012","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.humpath.2026.106072_bib50","first-page":"5615","article-title":"Mutations in the SDHB gene are associated with extra-adrenal and\/or malignant phaeochromocytomas","volume":"63","author":"Gimenez-Roqueplo","year":"2003","journal-title":"Cancer Res"},{"key":"10.1016\/j.humpath.2026.106072_bib51","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1677\/ERC-08-0284","article-title":"Clinical aspects of SDHx-related pheochromocytoma and paraganglioma","volume":"16","author":"Timmers","year":"2009","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.humpath.2026.106072_bib52","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1007\/s00432-017-2397-3","article-title":"SDHB-related pheochromocytoma and paraganglioma penetrance and genotype-phenotype correlations","volume":"143","author":"Jochmanova","year":"2017","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.humpath.2026.106072_bib53","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1097\/PAS.0000000000000534","article-title":"Urinary bladder paragangliomas: how immunohistochemistry can assist to identify patients with SDHB germline and somatic mutations","volume":"39","author":"Giubellino","year":"2015","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2026.106072_bib54","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1121397","article-title":"SDHB immunohistochemistry for prognosis of pheochromocytoma and paraganglioma: a retrospective and prospective analysis","volume":"14","author":"Su","year":"2023","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.humpath.2026.106072_bib55","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1097\/PAS.0b013e318293d83c","article-title":"Identification of succinate dehydrogenase-deficient bladder paragangliomas","volume":"37","author":"Mason","year":"2013","journal-title":"Am J Surg Pathol"}],"container-title":["Human Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817726000419?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817726000419?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,19]],"date-time":"2026-04-19T05:10:30Z","timestamp":1776575430000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0046817726000419"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":55,"alternative-id":["S0046817726000419"],"URL":"https:\/\/doi.org\/10.1016\/j.humpath.2026.106072","relation":{},"ISSN":["0046-8177"],"issn-type":[{"value":"0046-8177","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"S100 expression and SDHB status define distinct biological subsets of bladder paraganglioma","name":"articletitle","label":"Article Title"},{"value":"Human Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humpath.2026.106072","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"106072"}}